Gene Editing Breakthrough Offers New Hope for Beta Thalassaemia Patients A new clinical trial has delivered powerful evidence that gene editing can successfully treat β-Thalassaemia, a genetic blood disorder closely related to sickle-cell anemia. Unl...

Markdown supported · ⌘↵ to post
No responses yet.